Skip to main content
. 2020 Mar 5;12:1641–1647. doi: 10.2147/CMAR.S227348

Figure 1.

Figure 1

MIR503HG and cyclin D1 were dysregulated in NSCLC. RT-qPCR analyzed by paired t-test showed that, comparing to non-cancer tissues, MIR503HG was significantly downregulated (A), and cyclin D1 was significantly upregulated (B) in NSCLC tissues collected from the 64 NSCLC patients (*p<0.05).